罗斯-ATM-CHK2轴稳定HIF-1α,并在缺氧微环境中促进瘤血管生成
Ming Bai1, Pengzhi Xu2, Rong Cheng3,4
1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.
Oncogene
|March 8, 2025
概括
检查点激酶CHK2通过抑制其全方位化和促进双化,在固体瘤中稳定缺氧诱导因子1-alpha (HIF-1α). 这一发现为抗血管生成疗法提供了新的途径.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞信号传输 细胞信号传输
背景情况:
- 缺氧是瘤发育和进展的关键因素.
- 低氧诱导因子1-α (HIF-1α) 在瘤细胞适应低氧环境中起着关键作用.
- HIF-1α的稳定性对于瘤细胞的生存和增殖至关重要.
研究的目的:
- 在低氧条件下阐明一种控制HIF-1α稳定性在固体瘤中的新型调节机制.
- 研究检查点激酶CHK2在HIF-1α调节中的作用.
- 探索抗血管生成疗法的潜在治疗点.
主要方法:
- 在低氧条件下研究了CHK2和HIF-1α之间的相互作用.
- 分析了CHK2对HIF-1α泛化和酸化的影响.
- 研究了一种特定的氨酸残留物 (Thr645) 在HIF-1α调节中的作用.
- 评估了CHK2-介导修改对HIF-1α和USP7.7.之间的相互作用的影响.
主要成果:
- 检查点激酶CHK2在缺氧下与HIF-1α结合,抑制其无处不在.
- 在Thr645中CHK2诱导的HIF-1α酸化促进了与二维基因化酶USP7.7.一起复合的形成.
- 这种相互作用增强了缺氧固体瘤中的HIF-1α稳定性.
- 通过CHK2调解的HIF-1α的酸化和无处可见化之间的新型交叉被确定.
结论:
- 一个涉及CHK2,HIF-1α酸化和USP7的新型调节途径稳定了缺氧瘤中的HIF-1α.
- 这种机制增加了对HIF-1α翻译后修改的理解.
- 这些发现为开发针对瘤缺氧的抗血管生成疗法提供了新的见解.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K